Rare diseases
Investigational molecules
Locations
Back to Estonia23 clinical trials in Pohja-Tallinna Linnaosa, Estonia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in EstoniaKliinilisedUuringud.ee(opens in a new tab)EstoniaEstoniaEstoniaEstoniaEstoniaEstoniaEstoniaEstoniaEstoniaEstoniaEstoniaEstoniaThe busiest research cities in the country
What the registry says about research in the country
Research focusing on evaluating treatments for multiple sclerosis, including long-term safety studies of medications like ocrelizumab and ofatumumab for patients with relapsing forms of MS.
Comprehensive studies investigating innovative therapies for inflammatory bowel diseases, including trials for both Crohn's Disease and Ulcerative Colitis using novel combination treatments.
Studies evaluating new treatments for stroke prevention and management of atrial fibrillation, including trials of novel anticoagulants and therapeutic approaches.
Clinical investigations focusing on bladder cancer treatments and complicated urinary tract infections, evaluating new therapeutic approaches and medication combinations.
Innovative studies examining treatments for various kidney conditions, including IgA Nephropathy and focal segmental glomerulosclerosis, with focus on long-term outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
